Theravance Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
07 Aug 24 | BuyUS$7,798,440 | Madison Avenue Partners, LP | Company | 999,800 | US$7.80 | |
01 May 24 | BuyUS$13,117,335 | Madison Avenue Partners, LP | Company | 1,499,124 | US$8.75 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 3,923,413 | 7.81% |
Institutions | 22,451,094 | 44.7% |
Hedge Funds | 23,829,158 | 47.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,511,150 | US$76.7m | 11.8% | 6.41% | |||
7,457,060 | US$60.1m | 0% | 4.21% | |||
4,100,000 | US$33.0m | 93% | 3.83% | |||
3,780,160 | US$30.5m | -10.2% | no data | |||
2,760,948 | US$22.3m | 0% | 4.21% | |||
2,002,179 | US$16.1m | -25.5% | no data | |||
1,920,366 | US$15.5m | -0.66% | no data | |||
1,700,000 | US$13.7m | 46.9% | 1.03% | |||
1,267,375 | US$10.2m | -7.41% | no data | |||
1,157,965 | US$9.3m | 0% | 0.25% | |||
1,000,000 | US$8.1m | 0% | 0.3% | |||
878,655 | US$7.1m | -57% | no data | |||
857,386 | US$6.9m | -11.4% | no data | |||
758,080 | US$6.1m | -3.01% | 0.01% | |||
586,614 | US$4.7m | 5.13% | 0.02% | |||
476,158 | US$3.8m | -8.52% | no data | |||
464,967 | US$3.7m | -4.87% | no data | |||
350,587 | US$2.8m | 5.93% | no data | |||
342,613 | US$2.8m | -2.63% | no data | |||
341,421 | US$2.8m | 115% | no data | |||
330,181 | US$2.7m | 38.4% | no data | |||
326,743 | US$2.6m | -3.89% | no data | |||
322,992 | US$2.6m | 7.33% | no data | |||
321,366 | US$2.6m | -2.62% | no data | |||
297,499 | US$2.4m | 83.6% | no data |